name,category,termsBCS1-like (yeast),INTERPRO[450003154$IPR003593:ATPase, AAA+ type, core, 450003482$IPR003959:ATPase, AAA-type, core, 450003483$IPR003960:ATPase, AAA-type, conserved site, 450013300$IPR014851:BCS1, N-terminal]
BCS1-like (yeast),OMIM_DISEASE[520000573$Bjornstad syndrome, 520000574$Bjornstad syndrome (pili torti and deafness), 520002184$GRACILE syndrome, 520002806$Leigh syndrome, 520003337$Mitochondrial complex III deficiency]
BCS1-like (yeast),SMART[760000335$SM00382:AAA]
BCS1-like (yeast),SP_PIR_KEYWORDS[790000138$atp-binding, 790000288$Chaperone, 790000356$complete proteome, 790000415$deafness, 790000446$disease mutation, 790000919$membrane, 790000969$mitochondrion, 790000970$mitochondrion inner membrane, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001555$transmembrane]
BCS1-like (yeast),UP_SEQ_FEATURE[850031852$chain:Mitochondrial chaperone BCS1, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant, 850118594$topological domain:Mitochondrial intermembrane, 850118596$topological domain:Mitochondrial matrix, 850118623$transmembrane region]
CD2 (cytoplasmic tail) binding protein 2,INTERPRO[450002786$IPR003169:GYF]
CD2 (cytoplasmic tail) binding protein 2,PIR_SUPERFAMILY[630029529$PIRSF037959:CD2 antigen cytoplasmic tail-binding protein 2]
CD2 (cytoplasmic tail) binding protein 2,SMART[760000390$SM00444:GYF]
CD2 (cytoplasmic tail) binding protein 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000407$cytoplasm, 790001162$phosphoprotein, 790001212$polymorphism]
CD2 (cytoplasmic tail) binding protein 2,UP_SEQ_FEATURE[850010131$chain:CD2 antigen cytoplasmic tail-binding protein 2, 850104094$domain:GYF, 850105852$helix, 850106258$modified residue, 850117295$sequence variant, 850118575$strand]
Finkel-Biskis-Reilly murine sarcoma virus (FBR-MuSV) ubiquitously expressed,INTERPRO[450000534$IPR000626:Ubiquitin, 450006249$IPR006846:Ribosomal protein S30, 450018184$IPR019954:Ubiquitin conserved site, 450018185$IPR019955:Ubiquitin supergroup, 450018186$IPR019956:Ubiquitin subgroup]
Finkel-Biskis-Reilly murine sarcoma virus (FBR-MuSV) ubiquitously expressed,KEGG_PATHWAY[470038813$hsa03010:Ribosome]
Finkel-Biskis-Reilly murine sarcoma virus (FBR-MuSV) ubiquitously expressed,PIR_SUPERFAMILY[630002173$PIRSF002034:ubiquitin, 630002359$PIRSF002227:ribosomal protein S30e]
Finkel-Biskis-Reilly murine sarcoma virus (FBR-MuSV) ubiquitously expressed,SMART[760000186$SM00213:UBQ]
Finkel-Biskis-Reilly murine sarcoma virus (FBR-MuSV) ubiquitously expressed,SP_PIR_KEYWORDS[790000356$complete proteome, 790000445$direct protein sequencing, 790001212$polymorphism, 790001255$protein biosynthesis, 790001325$ribonucleoprotein, 790001329$ribosomal protein, 790001330$ribosome]
Finkel-Biskis-Reilly murine sarcoma virus (FBR-MuSV) ubiquitously expressed,UP_SEQ_FEATURE[850002053$chain:40S ribosomal protein S30, 850068144$chain:Ubiquitin-like protein FUBI, 850117295$sequence variant]
G protein regulated inducer of neurite outgrowth 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000264$cell membrane, 790000267$cell projection, 790000356$complete proteome, 790000881$lipoprotein, 790000919$membrane, 790001100$palmitate, 790001162$phosphoprotein, 790001212$polymorphism]
G protein regulated inducer of neurite outgrowth 1,UP_SEQ_FEATURE[850020258$chain:G protein-regulated inducer of neurite outgrowth 1, 850105898$lipid moiety-binding region:S-palmitoyl cysteine, 850106258$modified residue, 850112370$region of interest:Interaction with GNAO1, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
Rho family GTPase 2,INTERPRO[450001599$IPR001806:Ras GTPase, 450003145$IPR003578:Ras small GTPase, Rho type, 450004692$IPR005225:Small GTP-binding protein, 450012373$IPR013753:Ras]
Rho family GTPase 2,PIR_SUPERFAMILY[630028684$PIRSF037169:small GTPase, Rho type]
Rho family GTPase 2,SMART[760000148$SM00174:RHO]
Rho family GTPase 2,SP_PIR_KEYWORDS[790000356$complete proteome, 790000408$cytoplasmic vesicle, 790000639$gtp-binding, 790000881$lipoprotein, 790000919$membrane, 790000953$methylation, 790001063$nucleotide-binding, 790001236$prenylation]
Rho family GTPase 2,UP_SEQ_FEATURE[850057605$chain:Rho-related GTP-binding protein RhoN, 850105894$lipid moiety-binding region:S-geranylgeranyl cysteine, 850106258$modified residue, 850106296$nucleotide phosphate-binding region:GTP, 850109701$propeptide:Removed in mature form, 850117441$short sequence motif:Effector region]
SEC14-like 3 (S. cerevisiae),INTERPRO[450000939$IPR001071:Cellular retinaldehyde binding/alpha-tocopherol transport, 450001103$IPR001251:Cellular retinaldehyde-binding/triple function, C-terminal, 450007565$IPR008273:Cellular retinaldehyde-binding/triple function, N-terminal, 450008192$IPR009038:GOLD]
SEC14-like 3 (S. cerevisiae),SMART[760000458$SM00516:SEC14]
SEC14-like 3 (S. cerevisiae),SP_PIR_KEYWORDS[790000356$complete proteome, 790000876$lipid-binding, 790001212$polymorphism, 790001558$transport]
SEC14-like 3 (S. cerevisiae),UP_SEQ_FEATURE[850059083$chain:SEC14-like protein 3, 850103410$domain:CRAL-TRIO, 850104069$domain:GOLD, 850117295$sequence variant]
TLC domain containing 2,INTERPRO[450006052$IPR006634:TRAM, LAG1 and CLN8 homology]
TLC domain containing 2,SMART[760000630$SM00724:TLC]
TLC domain containing 2,SP_PIR_KEYWORDS[790000356$complete proteome, 790000919$membrane, 790001555$transmembrane]
TLC domain containing 2,UP_SEQ_FEATURE[850064533$chain:TLC domain-containing protein 2, 850105531$domain:TLC, 850118623$transmembrane region]
WD repeat domain 82,INTERPRO[450001490$IPR001680:WD40 repeat, 450014355$IPR015943:WD40/YVTN repeat-like, 450016294$IPR017986:WD40 repeat, region, 450018010$IPR019775:WD40 repeat, conserved site, 450018016$IPR019781:WD40 repeat, subgroup, 450018017$IPR019782:WD40 repeat 2]
WD repeat domain 82,SMART[760000289$SM00320:WD40]
WD repeat domain 82,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790001065$nucleus, 790001162$phosphoprotein, 790001304$repeat, 790001638$wd repeat]
WD repeat domain 82,UP_SEQ_FEATURE[850100782$chain:WD repeat-containing protein 82, 850106258$modified residue, 850117171$repeat:WD 1, 850117182$repeat:WD 2, 850117193$repeat:WD 3, 850117195$repeat:WD 4, 850117196$repeat:WD 5, 850117197$repeat:WD 6]
aspartate beta-hydroxylase domain containing 1,INTERPRO[450007154$IPR007803:Aspartyl/Asparaginyl beta-hydroxylase]
aspartate beta-hydroxylase domain containing 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000437$dioxygenase, 790000919$membrane, 790001092$oxidoreductase, 790001162$phosphoprotein, 790001409$Signal-anchor, 790001555$transmembrane]
aspartate beta-hydroxylase domain containing 1,UP_SEQ_FEATURE[850006285$chain:Aspartate beta-hydroxylase domain- containing protein 1, 850102517$compositionally biased region:Gly-rich, 850106258$modified residue, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
bromodomain containing 2,INTERPRO[450001324$IPR001487:Bromodomain, 450016644$IPR018359:Bromodomain, conserved site]
bromodomain containing 2,SMART[760000267$SM00297:BROMO]
bromodomain containing 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000206$bromodomain, 790000356$complete proteome, 790000473$duplication, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat]
bromodomain containing 2,UP_SEQ_FEATURE[850008426$chain:Bromodomain-containing protein 2, 850102435$compositionally biased region:Arg/Lys-rich (highly basic), 850102516$compositionally biased region:Glu/Ser-rich, 850102572$compositionally biased region:Poly-Glu, 850102577$compositionally biased region:Poly-Lys, 850102580$compositionally biased region:Poly-Pro, 850102581$compositionally biased region:Poly-Ser, 850102597$compositionally biased region:Ser-rich, 850103167$domain:Bromo 1, 850103168$domain:Bromo 2, 850103720$domain:ET, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850117295$sequence variant, 850117610$short sequence motif:Nuclear localization signal, 850118574$splice variant, 850118624$turn]
calcium channel, voltage-dependent, N type, alpha 1B subunit,INTERPRO[450001840$IPR002077:Voltage-dependent calcium channel, alpha-1 subunit, 450004906$IPR005447:Voltage-dependent calcium channel, N-type, alpha-1 subunit, 450005268$IPR005821:Ion transport, 450013322$IPR014873:Voltage-dependent calcium channel, alpha-1 subunit, IQ domain, 450016534$IPR018249:EF-HAND 2]
calcium channel, voltage-dependent, N type, alpha 1B subunit,KEGG_PATHWAY[470038827$hsa04010:MAPK signaling pathway, 470038829$hsa04020:Calcium signaling pathway, 470038880$hsa04742:Taste transduction, 470038887$hsa04930:Type II diabetes mellitus]
calcium channel, voltage-dependent, N type, alpha 1B subunit,PIR_SUPERFAMILY[630005588$PIRSF005657:voltage-gated calcium channel]
calcium channel, voltage-dependent, N type, alpha 1B subunit,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000138$atp-binding, 790000211$calcium, 790000213$calcium channel, 790000215$calcium transport, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000798$ion transport, 790000799$ionic channel, 790000919$membrane, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001555$transmembrane, 790001558$transport, 790001631$voltage-gated channel]
calcium channel, voltage-dependent, N type, alpha 1B subunit,UP_SEQ_FEATURE[850100540$chain:Voltage-dependent N-type calcium channel subunit alpha-1B, 850102574$compositionally biased region:Poly-His, 850102581$compositionally biased region:Poly-Ser, 850103571$domain:EF-hand, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850111061$region of interest:Binding to the beta subunit, 850116205$repeat:I, 850116211$repeat:II, 850116226$repeat:III, 850116236$repeat:IV, 850117295$sequence variant, 850117960$site:Calcium ion selectivity and permeability, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
chondroadherin,COG_ONTOLOGY[90000070$Function unknown]
chondroadherin,INTERPRO[450000318$IPR000372:Leucine-rich repeat, cysteine-rich flanking region, N-terminal, 450000409$IPR000483:Cysteine-rich flanking region, C-terminal, 450001429$IPR001611:Leucine-rich repeat, 450003153$IPR003591:Leucine-rich repeat, typical subtype]
chondroadherin,KEGG_PATHWAY[470038853$hsa04510:Focal adhesion, 470038854$hsa04512:ECM-receptor interaction]
chondroadherin,SMART[760000007$SM00013:LRRNT, 760000071$SM00082:LRRCT, 760000333$SM00369:LRR_TYP]
chondroadherin,SP_PIR_KEYWORDS[790000356$complete proteome, 790000447$disulfide bond, 790000530$extracellular matrix, 790000616$glycoprotein, 790000853$leucine-rich repeat, 790001212$polymorphism, 790001304$repeat, 790001363$Secreted, 790001405$signal]
chondroadherin,UP_SEQ_FEATURE[850011228$chain:Chondroadherin, 850102883$disulfide bond, 850105822$glycosylation site:O-linked (GalNAc...), 850116308$repeat:LRR 1, 850116309$repeat:LRR 10, 850116310$repeat:LRR 11, 850116319$repeat:LRR 2, 850116330$repeat:LRR 3, 850116340$repeat:LRR 4, 850116341$repeat:LRR 5, 850116342$repeat:LRR 6, 850116343$repeat:LRR 7, 850116344$repeat:LRR 8, 850116346$repeat:LRR 9, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide]
chromosome 22 open reading frame 24,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000919$membrane, 790001212$polymorphism, 790001555$transmembrane]
chromosome 22 open reading frame 24,UP_SEQ_FEATURE[850073813$chain:Uncharacterized protein C22orf24, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
collagen, type XI, alpha 2,INTERPRO[450000772$IPR000885:Fibrillar collagen, C-terminal, 450001584$IPR001791:Laminin G, 450002753$IPR003129:Laminin G, thrombospondin-type, N-terminal, 450007490$IPR008160:Collagen triple helix repeat, 450011359$IPR012680:Laminin G, subdomain 2]
collagen, type XI, alpha 2,KEGG_PATHWAY[470038853$hsa04510:Focal adhesion, 470038854$hsa04512:ECM-receptor interaction]
collagen, type XI, alpha 2,OMIM_DISEASE[520001317$Deafness, autosomal dominant 13, 520001393$Deafness, autosomal recessive 53, 520003852$Otospondylomegaepiphyseal dysplasia, 520004698$Stickler syndrome, type III, 520005079$Weissenbacher-Zweymuller syndrome]
collagen, type XI, alpha 2,PIR_SUPERFAMILY[630002386$PIRSF002257:collagen alpha 1(V) chain]
collagen, type XI, alpha 2,SMART[760000030$SM00038:COLFI, 760000183$SM00210:TSPN, 760000253$SM00282:LamG]
collagen, type XI, alpha 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000345$collagen, 790000356$complete proteome, 790000415$deafness, 790000446$disease mutation, 790000447$disulfide bond, 790000530$extracellular matrix, 790000616$glycoprotein, 790000745$hydroxylation, 790000746$hydroxylysine, 790000747$hydroxyproline, 790001041$non-syndromic deafness, 790001212$polymorphism, 790001304$repeat, 790001363$Secreted, 790001405$signal, 790001446$stickler syndrome, 790001565$trimer, 790001568$triple helix]
collagen, type XI, alpha 2,UP_SEQ_FEATURE[850012209$chain:Collagen alpha-2(XI) chain, 850102572$compositionally biased region:Poly-Glu, 850103779$domain:Fibrillar collagen NC1, 850105553$domain:TSP N-terminal, 850105770$glycosylation site:N-linked (GlcNAc...), 850109651$propeptide:C-terminal propeptide, 850113761$region of interest:Nonhelical region, 850114937$region of interest:Triple-helical region, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant]
complement factor D (adipsin),BIOCARTA[30000016$h_alternativePathway:Alternative Complement Pathway, 30000067$h_compPathway:Complement Pathway]
complement factor D (adipsin),INTERPRO[450001106$IPR001254:Peptidase S1 and S6, chymotrypsin/Hap, 450001157$IPR001314:Peptidase S1A, chymotrypsin, 450016414$IPR018114:Peptidase S1/S6, chymotrypsin/Hap, active site]
complement factor D (adipsin),KEGG_PATHWAY[470038859$hsa04610:Complement and coagulation cascades]
complement factor D (adipsin),OMIM_DISEASE[520001138$Complement factor D deficiency]
complement factor D (adipsin),PIR_SUPERFAMILY[630001286$PIRSF001135:trypsin]
complement factor D (adipsin),SMART[760000013$SM00020:Tryp_SPc]
complement factor D (adipsin),SP_PIR_KEYWORDS[790000002$3d-structure, 790000352$complement alternate pathway, 790000356$complete proteome, 790000445$direct protein sequencing, 790000446$disease mutation, 790000447$disulfide bond, 790000743$hydrolase, 790000763$immune response, 790000777$innate immunity, 790001212$polymorphism, 790001252$Protease, 790001363$Secreted, 790001383$Serine protease, 790001405$signal, 790001652$zymogen]
complement factor D (adipsin),UP_SEQ_FEATURE[850000011$active site:Charge relay system, 850012385$chain:Complement factor D, 850102883$disulfide bond, 850104964$domain:Peptidase S1, 850105852$helix, 850109636$propeptide:Activation peptide, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118575$strand, 850118624$turn]
cytochrome P450, family 26, subfamily B, polypeptide 1,COG_ONTOLOGY[90000104$Secondary metabolites biosynthesis, transport, and catabolism]
cytochrome P450, family 26, subfamily B, polypeptide 1,INTERPRO[450000989$IPR001128:Cytochrome P450, 450002136$IPR002403:Cytochrome P450, E-class, group IV, 450016280$IPR017972:Cytochrome P450, conserved site, 450016281$IPR017973:Cytochrome P450, C-terminal region]
cytochrome P450, family 26, subfamily B, polypeptide 1,KEGG_PATHWAY[470038801$hsa00830:Retinol metabolism]
cytochrome P450, family 26, subfamily B, polypeptide 1,PIR_SUPERFAMILY[630000058$PIRSF000045:cytochrome P450 CYP2D6]
cytochrome P450, family 26, subfamily B, polypeptide 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000499$endoplasmic reticulum, 790000652$heme, 790000802$iron, 790000919$membrane, 790000937$metal-binding, 790000959$microsome, 790000984$Monooxygenase, 790001092$oxidoreductase, 790001212$polymorphism]
cytochrome P450, family 26, subfamily B, polypeptide 1,UP_SEQ_FEATURE[850013673$chain:Cytochrome P450 26B1, 850106026$metal ion-binding site:Iron (heme axial ligand), 850117295$sequence variant]
dynactin 4 (p62),INTERPRO[450007864$IPR008603:Dynactin p62]
dynactin 4 (p62),KEGG_PATHWAY[470038894$hsa05016:Huntington's disease]
dynactin 4 (p62),SP_PIR_KEYWORDS[790000012$acetylation, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790001212$polymorphism]
dynactin 4 (p62),UP_SEQ_FEATURE[850016481$chain:Dynactin subunit 4, 850106258$modified residue, 850117295$sequence variant]
espin-like,INTERPRO[450001870$IPR002110:Ankyrin]
espin-like,SMART[760000220$SM00248:ANK]
espin-like,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000086$ank repeat, 790000344$coiled coil, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat]
espin-like,UP_SEQ_FEATURE[850017841$chain:Espin-like protein, 850102586$compositionally biased region:Pro-rich, 850106258$modified residue, 850115632$repeat:ANK 1, 850115644$repeat:ANK 2, 850115654$repeat:ANK 3, 850115655$repeat:ANK 4, 850115656$repeat:ANK 5, 850115657$repeat:ANK 6, 850115658$repeat:ANK 7, 850115659$repeat:ANK 8, 850115660$repeat:ANK 9, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
family with sequence similarity 86, member B2; family with sequence similarity 86, member A; family with sequence similarity 86, member B1,INTERPRO[450017648$IPR019410:Methyltransferase-16, putative]
family with sequence similarity 86, member B2; family with sequence similarity 86, member A; family with sequence similarity 86, member B1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001212$polymorphism]
family with sequence similarity 86, member B2; family with sequence similarity 86, member A; family with sequence similarity 86, member B1,UP_SEQ_FEATURE[850046075$chain:Protein FAM86A, 850046076$chain:Protein FAM86B1, 850046077$chain:Protein FAM86B2, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
glucokinase (hexokinase 4) regulator,INTERPRO[450004942$IPR005486:Glucokinase regulatory, conserved site]
glucokinase (hexokinase 4) regulator,OMIM_DISEASE[520001123$Common genetic variation near MC4R is associated with waist circumference and insulin resistance, 520001129$Common variants at 30 loci contribute to polygenic dyslipidemia, 520001995$Genome-wide association analysis of metabolic traits in a birth cohort from a founder population, 520002013$Genome-wide association study identifies genes for biomarkers of cardiovascular disease: serum urate and dyslipidemia, 520002930$Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts, 520002932$Loci Related to Metabolic-Syndrome Pathways Including LEPR, HNF1A, IL6R, and GCKR Associate with Plasma C-Reactive Protein: The Women's Genome Health Study, 520003638$Newly identified loci that influence lipid concentrations and risk of coronary artery disease, 520004490$Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans]
glucokinase (hexokinase 4) regulator,PIR_SUPERFAMILY[630001834$PIRSF001668:glucokinase regulator]
glucokinase (hexokinase 4) regulator,SP_PIR_KEYWORDS[790000356$complete proteome, 790001212$polymorphism, 790001304$repeat]
glucokinase (hexokinase 4) regulator,UP_SEQ_FEATURE[850021375$chain:Glucokinase regulatory protein, 850105364$domain:SIS 1, 850105365$domain:SIS 2, 850117295$sequence variant]
glutamate receptor, ionotropic, N-methyl D-aspartate-associated protein 1 (glutamate binding),INTERPRO[450005639$IPR006213:Bax inhibitor 1, conserved site, 450005640$IPR006214:Uncharacterised protein family UPF0005]
glutamate receptor, ionotropic, N-methyl D-aspartate-associated protein 1 (glutamate binding),SP_PIR_KEYWORDS[790000356$complete proteome, 790000919$membrane, 790001212$polymorphism, 790001555$transmembrane]
glutamate receptor, ionotropic, N-methyl D-aspartate-associated protein 1 (glutamate binding),UP_SEQ_FEATURE[850021596$chain:Glutamate [NMDA] receptor-associated protein 1, 850102586$compositionally biased region:Pro-rich, 850117294$sequence conflict, 850117295$sequence variant, 850118623$transmembrane region]
guanine nucleotide binding protein (G protein), alpha 11 (Gq class),BIOCARTA[30000039$h_biopeptidesPathway:Bioactive Peptide Induced Signaling Pathway]
guanine nucleotide binding protein (G protein), alpha 11 (Gq class),INTERPRO[450000561$IPR000654:G-protein alpha subunit, group Q, 450000892$IPR001019:Guanine nucleotide binding protein (G-protein), alpha subunit, 450002582$IPR002928:Myosin tail, 450014086$IPR015650:Heavy chain of Myosin]
guanine nucleotide binding protein (G protein), alpha 11 (Gq class),KEGG_PATHWAY[470038829$hsa04020:Calcium signaling pathway, 470038845$hsa04270:Vascular smooth muscle contraction, 470038858$hsa04540:Gap junction, 470038878$hsa04730:Long-term depression, 470038883$hsa04912:GnRH signaling pathway]
guanine nucleotide binding protein (G protein), alpha 11 (Gq class),PIR_SUPERFAMILY[630002519$PIRSF002400:GTP-binding regulatory protein Gs alpha chain]
guanine nucleotide binding protein (G protein), alpha 11 (Gq class),SP_PIR_KEYWORDS[790000028$ADP-ribosylation, 790000344$coiled coil, 790000356$complete proteome, 790000445$direct protein sequencing, 790000637$GTP binding, 790000639$gtp-binding, 790000687$heterotrimer, 790000986$motor protein, 790000997$muscle protein, 790001002$myosin, 790001059$nucleotide binding, 790001063$nucleotide-binding, 790001097$P-loop, 790001407$signal transduction, 790001504$thick filament, 790001546$transducer]
guanine nucleotide binding protein (G protein), alpha 11 (Gq class),UP_SEQ_FEATURE[850022748$chain:Guanine nucleotide-binding protein subunit alpha-11, 850106258$modified residue, 850106296$nucleotide phosphate-binding region:GTP, 850117294$sequence conflict]
histone cluster 1, H1t,INTERPRO[450005266$IPR005818:Histone H1/H5, 450005267$IPR005819:Histone H5, 450010816$IPR011991:Winged helix repressor DNA-binding]
histone cluster 1, H1t,PIR_SUPERFAMILY[630029831$PIRSF038219:histone H1]
histone cluster 1, H1t,SMART[760000466$SM00526:H15]
histone cluster 1, H1t,SP_PIR_KEYWORDS[790000011$acetylated amino end, 790000012$acetylation, 790000315$chromosomal protein, 790000356$complete proteome, 790000428$developmental protein, 790000434$differentiation, 790000449$DNA binding, 790000466$dna-binding, 790001057$nucleosome, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001426$spermatogenesis]
histone cluster 1, H1t,UP_SEQ_FEATURE[850023965$chain:Histone H1t, 850106258$modified residue, 850111754$region of interest:Globular, 850117295$sequence variant]
hypothetical protein LOC100133632; family with sequence similarity 101, member B,SP_PIR_KEYWORDS[790000356$complete proteome]
hypothetical protein LOC100133632; family with sequence similarity 101, member B,UP_SEQ_FEATURE[850045812$chain:Protein FAM101B, 850102573$compositionally biased region:Poly-Gly]
interferon induced transmembrane protein 5,INTERPRO[450006944$IPR007593:Interferon-induced transmembrane protein]
interferon induced transmembrane protein 5,PIR_SUPERFAMILY[630013367$PIRSF016581:interferon-induced transmembrane protein]
interferon induced transmembrane protein 5,SP_PIR_KEYWORDS[790000356$complete proteome, 790000919$membrane, 790001212$polymorphism, 790001555$transmembrane]
interferon induced transmembrane protein 5,UP_SEQ_FEATURE[850026467$chain:Interferon-induced transmembrane protein 5, 850117295$sequence variant, 850118623$transmembrane region]
iroquois homeobox 5,INTERPRO[450001200$IPR001356:Homeobox, 450003418$IPR003893:Iroquois-class homeodomain protein, 450010997$IPR012287:Homeodomain-related, 450016278$IPR017970:Homeobox, conserved site]
iroquois homeobox 5,SMART[760000341$SM00389:HOX, 760000488$SM00548:IRO]
iroquois homeobox 5,SP_PIR_KEYWORDS[790000356$complete proteome, 790000466$dna-binding, 790000699$Homeobox, 790001065$nucleus, 790001377$sensory transduction, 790001622$vision, 790001628$vitamin d]
iroquois homeobox 5,UP_SEQ_FEATURE[850026829$chain:Iroquois-class homeodomain protein irx-5, 850102565$compositionally biased region:Poly-Ala, 850102572$compositionally biased region:Poly-Glu, 850102573$compositionally biased region:Poly-Gly, 850102580$compositionally biased region:Poly-Pro, 850102935$DNA-binding region:Homeobox; TALE-type, 850117294$sequence conflict]
pantothenate kinase 2,INTERPRO[450004060$IPR004567:Eukaryotic pantothenate kinase, 450010433$IPR011602:Fumble]
pantothenate kinase 2,KEGG_PATHWAY[470038797$hsa00770:Pantothenate and CoA biosynthesis]
pantothenate kinase 2,OMIM_DISEASE[520002217$HARP syndrome, 520003592$Neurodegeneration with brain iron accumulation 1 (Hallervorden-Spatz syndrome), 520003593$Neurodegeneration, pantothenate kinase-associated]
pantothenate kinase 2,PIR_SUPERFAMILY[630008504$PIRSF009355:pantothenate kinase, acetyl-CoA regulated, stand-alone type]
pantothenate kinase 2,SP_PIR_KEYWORDS[790000050$alternative initiation, 790000053$alternative splicing, 790000138$atp-binding, 790000342$coenzyme a biosynthesis, 790000356$complete proteome, 790000407$cytoplasm, 790000446$disease mutation, 790000825$kinase, 790000969$mitochondrion, 790001015$neurodegeneration, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001547$transferase, 790001550$transit peptide]
pantothenate kinase 2,UP_SEQ_FEATURE[850036793$chain:Pantothenate kinase 2, mitochondrial, 850102572$compositionally biased region:Poly-Glu, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118617$transit peptide:Mitochondrion]
platelet-derived growth factor receptor, beta polypeptide,BBID[10000094$73.Integrins_and_other_cell-surface_receptors]
platelet-derived growth factor receptor, beta polypeptide,INTERPRO[450000618$IPR000719:Protein kinase, core, 450001096$IPR001245:Tyrosine protein kinase, 450001615$IPR001824:Receptor tyrosine kinase, class III, conserved site, 450003159$IPR003598:Immunoglobulin subtype 2, 450003160$IPR003599:Immunoglobulin subtype, 450006486$IPR007110:Immunoglobulin-like, 450007559$IPR008266:Tyrosine protein kinase, active site, 450008254$IPR009134:Vascular endothelial growth factor receptor, VEGFR, N-terminal, 450011788$IPR013151:Immunoglobulin, 450012396$IPR013783:Immunoglobulin-like fold, 450014567$IPR016243:Tyrosine-protein kinase, CSF-1/PDGF receptor, 450015769$IPR017441:Protein kinase, ATP binding site]
platelet-derived growth factor receptor, beta polypeptide,KEGG_PATHWAY[470038827$hsa04010:MAPK signaling pathway, 470038829$hsa04020:Calcium signaling pathway, 470038830$hsa04060:Cytokine-cytokine receptor interaction, 470038853$hsa04510:Focal adhesion, 470038858$hsa04540:Gap junction, 470038881$hsa04810:Regulation of actin cytoskeleton, 470038899$hsa05200:Pathways in cancer, 470038900$hsa05210:Colorectal cancer, 470038904$hsa05214:Glioma, 470038905$hsa05215:Prostate cancer, 470038908$hsa05218:Melanoma]
platelet-derived growth factor receptor, beta polypeptide,OMIM_DISEASE[520003467$Myelomonocytic leukemia, chronic, 520003470$Myeloproliferative disorder with eosinophilia]
platelet-derived growth factor receptor, beta polypeptide,PIR_SUPERFAMILY[630000724$PIRSF000615:tyrosine-protein kinase, CSF-1/PDGF receptor type, 630000725$PIRSF000615:TyrPK_CSF1-R, 630031083$PIRSF500948:beta-type platelet-derived growth factor receptor]
platelet-derived growth factor receptor, beta polypeptide,SMART[760000192$SM00219:TyrKc, 760000356$SM00408:IGc2, 760000357$SM00409:IG]
platelet-derived growth factor receptor, beta polypeptide,SP_PIR_KEYWORDS[790000002$3d-structure, 790000134$ATP, 790000138$atp-binding, 790000149$autophosphorylation, 790000316$chromosomal rearrangement, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000616$glycoprotein, 790000634$growth factor receptor, 790000679$heterodimer, 790000701$homodimer, 790000768$Immunoglobulin domain, 790000825$kinase, 790000919$membrane, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001168$phosphotransferase, 790001212$polymorphism, 790001271$Proto-oncogene, 790001301$receptor, 790001304$repeat, 790001405$signal, 790001547$transferase, 790001555$transmembrane, 790001556$transmembrane protein, 790001586$tyrosine-protein kinase, 790001588$tyrosine-specific protein kinase]
platelet-derived growth factor receptor, beta polypeptide,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850007905$chain:Beta-type platelet-derived growth factor receptor, 850102883$disulfide bond, 850104356$domain:Ig-like C2-type 1, 850104367$domain:Ig-like C2-type 2, 850104378$domain:Ig-like C2-type 3, 850104389$domain:Ig-like C2-type 4, 850104400$domain:Ig-like C2-type 5, 850105086$domain:Protein kinase, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850117850$site:Breakpoint for insertion to form PDE4DIP- PDGFRB fusion protein, 850117951$site:Breakpoint for translocation to form TRIP11-PDGFRB, 850118575$strand, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region, 850118624$turn]
pleckstrin homology domain containing, family H (with MyTH4 domain) member 3,INTERPRO[450000257$IPR000299:FERM domain, 450000748$IPR000857:Unconventional myosin/plant kinesin-like protein/non-motor protein conserved region MyTH4, 450001635$IPR001849:Pleckstrin homology, 450010818$IPR011993:Pleckstrin homology-type, 450017984$IPR019747:FERM conserved site, 450017985$IPR019748:FERM central domain, 450017986$IPR019749:Band 4.1 domain]
pleckstrin homology domain containing, family H (with MyTH4 domain) member 3,SMART[760000121$SM00139:MyTH4, 760000205$SM00233:PH, 760000266$SM00295:B41]
pleckstrin homology domain containing, family H (with MyTH4 domain) member 3,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism, 790001405$signal]
pleckstrin homology domain containing, family H (with MyTH4 domain) member 3,UP_SEQ_FEATURE[850039569$chain:Pleckstrin homology domain-containing family H member 3, 850102581$compositionally biased region:Poly-Ser, 850103760$domain:FERM, 850104813$domain:MyTH4, 850104979$domain:PH, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant]
poliovirus receptor-related 2 (herpesvirus entry mediator B),INTERPRO[450003160$IPR003599:Immunoglobulin subtype, 450006486$IPR007110:Immunoglobulin-like, 450011750$IPR013106:Immunoglobulin V-set, 450011788$IPR013151:Immunoglobulin, 450011799$IPR013162:CD80-like, immunoglobulin C2-set, 450012396$IPR013783:Immunoglobulin-like fold]
poliovirus receptor-related 2 (herpesvirus entry mediator B),KEGG_PATHWAY[470038855$hsa04514:Cell adhesion molecules (CAMs), 470038856$hsa04520:Adherens junction]
poliovirus receptor-related 2 (herpesvirus entry mediator B),OMIM_DISEASE[520000051$A genome-wide association study for late-onset Alzheimer's disease using DNA pooling]
poliovirus receptor-related 2 (herpesvirus entry mediator B),PIR_SUPERFAMILY[630002151$PIRSF002016:poliovirus receptor-related protein]
poliovirus receptor-related 2 (herpesvirus entry mediator B),SMART[760000357$SM00409:IG]
poliovirus receptor-related 2 (herpesvirus entry mediator B),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000256$cell adhesion, 790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000733$host-virus interaction, 790000768$Immunoglobulin domain, 790000919$membrane, 790001162$phosphoprotein, 790001301$receptor, 790001304$repeat, 790001405$signal, 790001555$transmembrane]
poliovirus receptor-related 2 (herpesvirus entry mediator B),UP_SEQ_FEATURE[850039669$chain:Poliovirus receptor-related protein 2, 850102883$disulfide bond, 850104356$domain:Ig-like C2-type 1, 850104367$domain:Ig-like C2-type 2, 850104407$domain:Ig-like V-type, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850106259$mutagenesis site, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
poly(rC) binding protein 1,INTERPRO[450003603$IPR004088:K Homology, type 1, 450016411$IPR018111:K Homology, type 1, subgroup]
poly(rC) binding protein 1,KEGG_PATHWAY[470038818$hsa03040:Spliceosome]
poly(rC) binding protein 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000466$dna-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001304$repeat, 790001325$ribonucleoprotein, 790001339$rna-binding]
poly(rC) binding protein 1,UP_SEQ_FEATURE[850039768$chain:Poly(rC)-binding protein 1, 850104521$domain:KH 1, 850104527$domain:KH 2, 850104528$domain:KH 3, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850118575$strand]
polymerase (RNA) II (DNA directed) polypeptide E, 25kDa,INTERPRO[450000678$IPR000783:RNA polymerase, subunit H/Rpb5 C-terminal, 450005022$IPR005571:RNA polymerase, Rpb5, N-terminal, 450012958$IPR014381:DNA-directed RNA polymerase, RPB5 subunit]
polymerase (RNA) II (DNA directed) polypeptide E, 25kDa,KEGG_PATHWAY[470038742$hsa00230:Purine metabolism, 470038744$hsa00240:Pyrimidine metabolism, 470038815$hsa03020:RNA polymerase, 470038894$hsa05016:Huntington's disease]
polymerase (RNA) II (DNA directed) polypeptide E, 25kDa,PIR_SUPERFAMILY[630000867$PIRSF000747:DNA-directed RNA polymerase, RPB5 subunit, 630000868$PIRSF000747:RPB5]
polymerase (RNA) II (DNA directed) polypeptide E, 25kDa,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000445$direct protein sequencing, 790000468$dna-directed rna polymerase, 790000733$host-virus interaction, 790001064$nucleotidyltransferase, 790001065$nucleus, 790001212$polymorphism, 790001539$Transcription]
polymerase (RNA) II (DNA directed) polypeptide E, 25kDa,UP_SEQ_FEATURE[850016114$chain:DNA-directed RNA polymerases I, II, and III subunit RPABC1, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant]
proteasome (prosome, macropain) subunit, beta type, 8 (large multifunctional peptidase 7),COG_ONTOLOGY[90000095$Posttranslational modification, protein turnover, chaperones]
proteasome (prosome, macropain) subunit, beta type, 8 (large multifunctional peptidase 7),INTERPRO[450000211$IPR000243:Peptidase T1A, proteasome beta-subunit, 450001196$IPR001353:Proteasome, alpha and beta subunits, 450001197$IPR001353:Proteasome, subunit alpha/beta, 450014435$IPR016050:Proteasome, beta-type subunit, conserved site]
proteasome (prosome, macropain) subunit, beta type, 8 (large multifunctional peptidase 7),KEGG_PATHWAY[470038819$hsa03050:Proteasome]
proteasome (prosome, macropain) subunit, beta type, 8 (large multifunctional peptidase 7),PIR_SUPERFAMILY[630001352$PIRSF001212:multicatalytic endopeptidase complex chain C9]
proteasome (prosome, macropain) subunit, beta type, 8 (large multifunctional peptidase 7),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000733$host-virus interaction, 790000743$hydrolase, 790000763$immune response, 790001065$nucleus, 790001212$polymorphism, 790001252$Protease, 790001254$proteasome, 790001267$proteinase, 790001516$threonine protease, 790001652$zymogen]
proteasome (prosome, macropain) subunit, beta type, 8 (large multifunctional peptidase 7),UP_SEQ_FEATURE[850000090$active site:Nucleophile, 850044896$chain:Proteasome subunit beta type-8, 850109701$propeptide:Removed in mature form, 850117295$sequence variant, 850118005$site:Cleavage; by autocatalysis, 850118574$splice variant]
protocadherin gamma subfamily C, 3; protocadherin gamma subfamily C, 5; protocadherin gamma subfamily C, 4; protocadherin gamma subfamily A, 12,INTERPRO[450001884$IPR002126:Cadherin, 450011801$IPR013164:Cadherin, N-terminal, 450013933$IPR015492:Protocadherin gamma]
protocadherin gamma subfamily C, 3; protocadherin gamma subfamily C, 5; protocadherin gamma subfamily C, 4; protocadherin gamma subfamily A, 12,SMART[760000099$SM00112:CA]
protocadherin gamma subfamily C, 3; protocadherin gamma subfamily C, 5; protocadherin gamma subfamily C, 4; protocadherin gamma subfamily A, 12,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000211$calcium, 790000256$cell adhesion, 790000264$cell membrane, 790000356$complete proteome, 790000616$glycoprotein, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001405$signal, 790001555$transmembrane]
protocadherin gamma subfamily C, 3; protocadherin gamma subfamily C, 5; protocadherin gamma subfamily C, 4; protocadherin gamma subfamily A, 12,UP_SEQ_FEATURE[850048727$chain:Protocadherin gamma-A12, 850048743$chain:Protocadherin gamma-C3, 850048744$chain:Protocadherin gamma-C4, 850048745$chain:Protocadherin gamma-C5, 850103211$domain:Cadherin 1, 850103222$domain:Cadherin 2, 850103233$domain:Cadherin 3, 850103239$domain:Cadherin 4, 850103240$domain:Cadherin 5, 850103241$domain:Cadherin 6, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
retinoid X receptor, beta,INTERPRO[450000002$IPR000003:Retinoid X receptor, 450000459$IPR000536:Nuclear hormone receptor, ligand-binding, core, 450001442$IPR001628:Zinc finger, nuclear hormone receptor-type, 450001527$IPR001723:Steroid hormone receptor, 450008168$IPR008946:Nuclear hormone receptor, ligand-binding, 450011732$IPR013088:Zinc finger, NHR/GATA-type]
retinoid X receptor, beta,KEGG_PATHWAY[470038821$hsa03320:PPAR signaling pathway, 470038886$hsa04920:Adipocytokine signaling pathway, 470038899$hsa05200:Pathways in cancer, 470038906$hsa05216:Thyroid cancer, 470038912$hsa05222:Small cell lung cancer, 470038913$hsa05223:Non-small cell lung cancer]
retinoid X receptor, beta,PIR_SUPERFAMILY[630002651$PIRSF002534:retinoic X receptor-like nuclear receptor, 630031000$PIRSF500848:retinoid X receptor (RXR)]
retinoid X receptor, beta,SMART[760000350$SM00399:ZnF_C4, 760000376$SM00430:HOLI]
retinoid X receptor, beta,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001301$receptor, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001649$zinc finger, 790001651$zinc-finger]
retinoid X receptor, beta,UP_SEQ_FEATURE[850057417$chain:Retinoic acid receptor RXR-beta, 850102586$compositionally biased region:Pro-rich, 850102946$DNA-binding region:Nuclear receptor, 850105852$helix, 850111880$region of interest:Hinge, 850113269$region of interest:Ligand-binding, 850113461$region of interest:Modulating, 850117294$sequence conflict, 850118575$strand, 850118624$turn, 850118866$zinc finger region:NR C4-type]
ribosomal protein L29 pseudogene 9; ribosomal protein L29 pseudogene 12; ribosomal protein L29 pseudogene 11; ribosomal protein L29; ribosomal protein L29 pseudogene 26,INTERPRO[450002371$IPR002673:Ribosomal protein L29e]
ribosomal protein L29 pseudogene 9; ribosomal protein L29 pseudogene 12; ribosomal protein L29 pseudogene 11; ribosomal protein L29; ribosomal protein L29 pseudogene 26,KEGG_PATHWAY[470038813$hsa03010:Ribosome]
ribosomal protein L29 pseudogene 9; ribosomal protein L29 pseudogene 12; ribosomal protein L29 pseudogene 11; ribosomal protein L29; ribosomal protein L29 pseudogene 26,PIR_SUPERFAMILY[630002372$PIRSF002240:ribosomal protein L29]
ribosomal protein L29 pseudogene 9; ribosomal protein L29 pseudogene 12; ribosomal protein L29 pseudogene 11; ribosomal protein L29; ribosomal protein L29 pseudogene 26,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000445$direct protein sequencing, 790000669$heparin-binding, 790000811$isopeptide bond, 790000953$methylation, 790001162$phosphoprotein, 790001255$protein biosynthesis, 790001304$repeat, 790001325$ribonucleoprotein, 790001329$ribosomal protein, 790001330$ribosome, 790001592$ubl conjugation]
ribosomal protein L29 pseudogene 9; ribosomal protein L29 pseudogene 12; ribosomal protein L29 pseudogene 11; ribosomal protein L29; ribosomal protein L29 pseudogene 26,UP_SEQ_FEATURE[850002713$chain:60S ribosomal protein L29, 850102720$cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), 850106258$modified residue, 850117294$sequence conflict]
selenocysteine lyase,COG_ONTOLOGY[90000095$Posttranslational modification, protein turnover, chaperones]
selenocysteine lyase,INTERPRO[450000163$IPR000192:Aminotransferase, class V/Cysteine desulfurase, 450013864$IPR015421:Pyridoxal phosphate-dependent transferase, major region, subdomain 1, 450014776$IPR016454:Cysteine desulfurase, NifS]
selenocysteine lyase,KEGG_PATHWAY[470038760$hsa00450:Selenoamino acid metabolism]
selenocysteine lyase,PIR_SUPERFAMILY[630005495$PIRSF005572:cysteine desulfurase, NifS type, 630005496$PIRSF005572:NifS]
selenocysteine lyase,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000891$lyase, 790001212$polymorphism, 790001283$pyridoxal phosphate, 790001547$transferase]
selenocysteine lyase,UP_SEQ_FEATURE[850000018$active site:Cysteine persulfide intermediate, 850059259$chain:Selenocysteine lyase, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
serpin peptidase inhibitor, clade B (ovalbumin), member 9,INTERPRO[450000186$IPR000215:Protease inhibitor I4, serpin, 450000208$IPR000240:Serpin B9 and maspin]
serpin peptidase inhibitor, clade B (ovalbumin), member 9,PIR_SUPERFAMILY[630001798$PIRSF001630:serpin]
serpin peptidase inhibitor, clade B (ovalbumin), member 9,SMART[760000081$SM00093:SERPIN]
serpin peptidase inhibitor, clade B (ovalbumin), member 9,SP_PIR_KEYWORDS[790000356$complete proteome, 790000407$cytoplasm, 790001253$protease inhibitor, 790001268$proteinase inhibitor, 790001385$Serine protease inhibitor]
serpin peptidase inhibitor, clade B (ovalbumin), member 9,UP_SEQ_FEATURE[850060379$chain:Serpin B9, 850118488$site:Reactive bond]
shisa homolog 5 (Xenopus laevis),KEGG_PATHWAY[470038836$hsa04115:p53 signaling pathway]
shisa homolog 5 (Xenopus laevis),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000109$Apoptosis, 790000356$complete proteome, 790000499$endoplasmic reticulum, 790000919$membrane, 790001065$nucleus, 790001212$polymorphism, 790001405$signal, 790001555$transmembrane]
shisa homolog 5 (Xenopus laevis),UP_SEQ_FEATURE[850047670$chain:Protein shisa-5, 850102582$compositionally biased region:Poly-Thr, 850102586$compositionally biased region:Pro-rich, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
similar to TRIMCyp; peptidylprolyl isomerase A (cyclophilin A); peptidylprolyl isomerase A (cyclophilin A)-like 3,BIOCARTA[30000156$h_il2rbPathway:IL-2 Receptor Beta Chain in T cell Activation]
similar to TRIMCyp; peptidylprolyl isomerase A (cyclophilin A); peptidylprolyl isomerase A (cyclophilin A)-like 3,INTERPRO[450001888$IPR002130:Peptidyl-prolyl cis-trans isomerase, cyclophilin-type]
similar to TRIMCyp; peptidylprolyl isomerase A (cyclophilin A); peptidylprolyl isomerase A (cyclophilin A)-like 3,PIR_SUPERFAMILY[630001630$PIRSF001467:peptidylprolyl isomerase]
similar to TRIMCyp; peptidylprolyl isomerase A (cyclophilin A); peptidylprolyl isomerase A (cyclophilin A)-like 3,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000356$complete proteome, 790000393$Cyclosporin, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000733$host-virus interaction, 790000810$Isomerase, 790000811$isopeptide bond, 790001162$phosphoprotein, 790001343$Rotamase, 790001592$ubl conjugation]
similar to TRIMCyp; peptidylprolyl isomerase A (cyclophilin A); peptidylprolyl isomerase A (cyclophilin A)-like 3,UP_SEQ_FEATURE[850037638$chain:Peptidyl-prolyl cis-trans isomerase A, 850102720$cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), 850105057$domain:PPIase cyclophilin-type, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850118575$strand, 850118624$turn]
small G protein signaling modulator 3,INTERPRO[450000166$IPR000195:RabGAP/TBC, 450001294$IPR001452:Src homology-3 domain, 450003532$IPR004012:RUN]
small G protein signaling modulator 3,SMART[760000143$SM00164:TBC, 760000295$SM00326:SH3, 760000527$SM00593:RUN]
small G protein signaling modulator 3,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000258$cell cycle, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000631$growth arrest, 790001212$polymorphism, 790001398$sh3 domain]
small G protein signaling modulator 3,UP_SEQ_FEATURE[850060997$chain:Small G protein signaling modulator 3, 850105135$domain:Rab-GAP TBC, 850105223$domain:RUN, 850105350$domain:SH3, 850117295$sequence variant, 850118574$splice variant]
stromal antigen 3-like 4,INTERPRO[450012342$IPR013721:STAG]
stromal antigen 3-like 4,SP_PIR_KEYWORDS[790000356$complete proteome, 790001212$polymorphism]
stromal antigen 3-like 4,UP_SEQ_FEATURE[850062323$chain:STAG3-like protein 4, 850117295$sequence variant]
transcription factor 19,INTERPRO[450000219$IPR000253:Forkhead-associated, 450001740$IPR001965:Zinc finger, PHD-type, 450018019$IPR019786:Zinc finger, PHD-type, conserved site, 450018020$IPR019787:Zinc finger, PHD-finger]
transcription factor 19,SMART[760000212$SM00240:FHA, 760000221$SM00249:PHD]
transcription factor 19,SP_PIR_KEYWORDS[790000356$complete proteome, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
transcription factor 19,UP_SEQ_FEATURE[850064981$chain:Transcription factor 19, 850102586$compositionally biased region:Pro-rich, 850103775$domain:FHA, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118877$zinc finger region:PHD-type]
transcription factor binding to IGHM enhancer 3,INTERPRO[450000957$IPR001092:Basic helix-loop-helix dimerisation region bHLH, 450010429$IPR011598:Helix-loop-helix DNA-binding]
transcription factor binding to IGHM enhancer 3,OMIM_DISEASE[520004228$Renal cell carcinoma, papillary, 1]
transcription factor binding to IGHM enhancer 3,SMART[760000321$SM00353:HLH]
transcription factor binding to IGHM enhancer 3,SP_PIR_KEYWORDS[790000020$activator, 790000316$chromosomal rearrangement, 790000356$complete proteome, 790000449$DNA binding, 790000466$dna-binding, 790000763$immune response, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001271$Proto-oncogene, 790001539$Transcription, 790001541$transcription factor, 790001543$transcription regulation, 790001592$ubl conjugation]
transcription factor binding to IGHM enhancer 3,UP_SEQ_FEATURE[850065156$chain:Transcription factor E3, 850102900$DNA-binding region:Basic motif, 850104114$domain:Helix-loop-helix motif, 850104712$domain:Leucine-zipper, 850106258$modified residue, 850114706$region of interest:Strong transcription activation domain, 850117294$sequence conflict, 850117295$sequence variant, 850117859$site:Breakpoint for translocation to form ASPSCR1-TFE3 oncogene, 850117917$site:Breakpoint for translocation to form NONO-TFE3, PSF-TFE3 and ASPSCR1-TFE3 oncogenes, 850117932$site:Breakpoint for translocation to form PRCC-TFE3 oncogene]
transient receptor potential cation channel, subfamily M, member 4,INTERPRO[450005268$IPR005821:Ion transport]
transient receptor potential cation channel, subfamily M, member 4,PIR_SUPERFAMILY[630030034$PIRSF038523:transient receptor potential cation channels TRPM4/TRPM5, 630031114$PIRSF500984:transient receptor potential cation channel TRPM4]
transient receptor potential cation channel, subfamily M, member 4,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000138$atp-binding, 790000211$calcium, 790000218$calmodulin-binding, 790000264$cell membrane, 790000344$coiled coil, 790000356$complete proteome, 790000763$immune response, 790000798$ion transport, 790000799$ionic channel, 790000919$membrane, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001555$transmembrane, 790001558$transport]
transient receptor potential cation channel, subfamily M, member 4,UP_SEQ_FEATURE[850065784$chain:Transient receptor potential cation channel subfamily M member 4, 850106258$modified residue, 850106259$mutagenesis site, 850111164$region of interest:Calmodulin-binding, 850113400$region of interest:Mediates modulation by decavanadate and PIP2-binding, 850117294$sequence conflict, 850117700$short sequence motif:Selectivity filter, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118603$topological domain:Pore forming, 850118623$transmembrane region]
transmembrane protein 115,INTERPRO[450012459$IPR013861:Protein of unknown function DUF1751, integral membrane, eukaryotic]
transmembrane protein 115,SP_PIR_KEYWORDS[790000356$complete proteome, 790000919$membrane, 790001162$phosphoprotein, 790001555$transmembrane]
transmembrane protein 115,UP_SEQ_FEATURE[850066014$chain:Transmembrane protein 115, 850106258$modified residue, 850118623$transmembrane region]
ubiquitin associated protein 1,INTERPRO[450014352$IPR015940:Ubiquitin-associated/translation elongation factor EF1B, N-terminal, eukaryote]
ubiquitin associated protein 1,SMART[760000144$SM00165:UBA]
ubiquitin associated protein 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat]
ubiquitin associated protein 1,UP_SEQ_FEATURE[850068056$chain:Ubiquitin-associated protein 1, 850105598$domain:UBA 1, 850105599$domain:UBA 2, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
von Hippel-Lindau tumor suppressor,BIOCARTA[30000138$h_hifPathway:Hypoxia-Inducible Factor in the Cardiovascular System, 30000307$h_vegfPathway:VEGF, Hypoxia, and Angiogenesis]
von Hippel-Lindau tumor suppressor,INTERPRO[450002407$IPR002714:Tumour suppressor protein, von Hippel-Lindau disease]
von Hippel-Lindau tumor suppressor,KEGG_PATHWAY[470038837$hsa04120:Ubiquitin mediated proteolysis, 470038899$hsa05200:Pathways in cancer, 470038901$hsa05211:Renal cell carcinoma]
von Hippel-Lindau tumor suppressor,OMIM_DISEASE[520002240$Hemangioblastoma, cerebellar, somatic, 520003978$Pheochromocytoma, 520004042$Polycythemia, benign familial, 520004230$Renal cell carcinoma, somatic, 520005051$von Hippel-Lindau syndrome]
von Hippel-Lindau tumor suppressor,PIR_SUPERFAMILY[630014449$PIRSF017788:von Hippel-Lindau disease tumor suppressor protein]
von Hippel-Lindau tumor suppressor,SP_PIR_KEYWORDS[790000002$3d-structure, 790000050$alternative initiation, 790000053$alternative splicing, 790000356$complete proteome, 790000361$congenital erythrocytosis, 790000407$cytoplasm, 790000446$disease mutation, 790000919$membrane, 790001065$nucleus, 790001212$polymorphism, 790001304$repeat, 790001580$tumor suppressor, 790001593$ubl conjugation pathway]
von Hippel-Lindau tumor suppressor,UP_SEQ_FEATURE[850100590$chain:Von Hippel-Lindau disease tumor suppressor, 850105852$helix, 850106259$mutagenesis site, 850110721$region of interest:8 X 5 AA tandem repeats of G-[PAVG]-E-E- [DAYSLE], 850112295$region of interest:Interaction with Elongin BC complex, 850113157$region of interest:Involved in binding to CCT complex, 850115074$repeat:1, 850115273$repeat:2, 850115417$repeat:3, 850115467$repeat:4, 850115506$repeat:5, 850115534$repeat:6, 850115553$repeat:7, 850115571$repeat:8, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
zinc finger protein 181,COG_ONTOLOGY[90000073$General function prediction only]
zinc finger protein 181,INTERPRO[450001691$IPR001909:Krueppel-associated  box, 450006475$IPR007087:Zinc finger, C2H2-type, 450011731$IPR013087:Zinc finger, C2H2-type/integrase, DNA-binding, 450014303$IPR015880:Zinc finger, C2H2-like]
zinc finger protein 181,PIR_SUPERFAMILY[630005483$PIRSF005559:zinc finger protein ZFP-36]
zinc finger protein 181,SMART[760000317$SM00349:KRAB, 760000323$SM00355:ZnF_C2H2]
zinc finger protein 181,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
zinc finger protein 181,UP_SEQ_FEATURE[850101475$chain:Zinc finger protein 181, 850104552$domain:KRAB, 850118574$splice variant, 850118656$zinc finger region:C2H2-type 1, 850118657$zinc finger region:C2H2-type 10, 850118660$zinc finger region:C2H2-type 11, 850118688$zinc finger region:C2H2-type 2, 850118711$zinc finger region:C2H2-type 3, 850118722$zinc finger region:C2H2-type 4, 850118725$zinc finger region:C2H2-type 5, 850118728$zinc finger region:C2H2-type 6, 850118731$zinc finger region:C2H2-type 7, 850118734$zinc finger region:C2H2-type 8, 850118737$zinc finger region:C2H2-type 9]
zinc finger protein 213,COG_ONTOLOGY[90000073$General function prediction only]
zinc finger protein 213,INTERPRO[450001691$IPR001909:Krueppel-associated  box, 450002887$IPR003309:Transcriptional regulator SCAN, 450006475$IPR007087:Zinc finger, C2H2-type, 450011731$IPR013087:Zinc finger, C2H2-type/integrase, DNA-binding, 450014303$IPR015880:Zinc finger, C2H2-like]
zinc finger protein 213,SMART[760000317$SM00349:KRAB, 760000323$SM00355:ZnF_C2H2, 760000377$SM00431:SCAN]
zinc finger protein 213,SP_PIR_KEYWORDS[790000356$complete proteome, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
zinc finger protein 213,UP_SEQ_FEATURE[850101495$chain:Zinc finger protein 213, 850104552$domain:KRAB, 850105271$domain:SCAN box, 850117294$sequence conflict, 850118656$zinc finger region:C2H2-type 1, 850118688$zinc finger region:C2H2-type 2, 850118711$zinc finger region:C2H2-type 3, 850118722$zinc finger region:C2H2-type 4, 850118725$zinc finger region:C2H2-type 5]
zinc finger protein 540,COG_ONTOLOGY[90000073$General function prediction only]
zinc finger protein 540,INTERPRO[450001691$IPR001909:Krueppel-associated  box, 450006475$IPR007087:Zinc finger, C2H2-type, 450011731$IPR013087:Zinc finger, C2H2-type/integrase, DNA-binding, 450014303$IPR015880:Zinc finger, C2H2-like]
zinc finger protein 540,SMART[760000317$SM00349:KRAB, 760000323$SM00355:ZnF_C2H2]
zinc finger protein 540,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
zinc finger protein 540,UP_SEQ_FEATURE[850101722$chain:Zinc finger protein 540, 850104552$domain:KRAB, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118656$zinc finger region:C2H2-type 1, 850118657$zinc finger region:C2H2-type 10, 850118660$zinc finger region:C2H2-type 11, 850118663$zinc finger region:C2H2-type 12, 850118666$zinc finger region:C2H2-type 13, 850118669$zinc finger region:C2H2-type 14, 850118671$zinc finger region:C2H2-type 15, 850118674$zinc finger region:C2H2-type 16, 850118676$zinc finger region:C2H2-type 17, 850118688$zinc finger region:C2H2-type 2, 850118711$zinc finger region:C2H2-type 3, 850118722$zinc finger region:C2H2-type 4, 850118725$zinc finger region:C2H2-type 5, 850118728$zinc finger region:C2H2-type 6, 850118731$zinc finger region:C2H2-type 7, 850118734$zinc finger region:C2H2-type 8, 850118737$zinc finger region:C2H2-type 9]
zinc finger protein 598,COG_ONTOLOGY[90000073$General function prediction only]
zinc finger protein 598,INTERPRO[450001628$IPR001841:Zinc finger, RING-type, 450006475$IPR007087:Zinc finger, C2H2-type, 450014303$IPR015880:Zinc finger, C2H2-like, 450016222$IPR017907:Zinc finger, RING-type, conserved site]
zinc finger protein 598,SMART[760000158$SM00184:RING, 760000323$SM00355:ZnF_C2H2]
zinc finger protein 598,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000937$metal-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001648$zinc, 790001651$zinc-finger]
zinc finger protein 598,UP_SEQ_FEATURE[850101781$chain:Zinc finger protein 598, 850102586$compositionally biased region:Pro-rich, 850106258$modified residue, 850117295$sequence variant, 850118574$splice variant, 850118655$zinc finger region:C2H2-type, 850118911$zinc finger region:RING-type]
zinc finger protein 619,COG_ONTOLOGY[90000073$General function prediction only]
zinc finger protein 619,INTERPRO[450001691$IPR001909:Krueppel-associated  box, 450006475$IPR007087:Zinc finger, C2H2-type, 450011731$IPR013087:Zinc finger, C2H2-type/integrase, DNA-binding, 450014303$IPR015880:Zinc finger, C2H2-like]
zinc finger protein 619,SMART[760000317$SM00349:KRAB, 760000323$SM00355:ZnF_C2H2]
zinc finger protein 619,SP_PIR_KEYWORDS[790000356$complete proteome, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
zinc finger protein 619,UP_SEQ_FEATURE[850101798$chain:Zinc finger protein 619, 850118656$zinc finger region:C2H2-type 1, 850118657$zinc finger region:C2H2-type 10, 850118688$zinc finger region:C2H2-type 2, 850118711$zinc finger region:C2H2-type 3, 850118722$zinc finger region:C2H2-type 4, 850118725$zinc finger region:C2H2-type 5, 850118728$zinc finger region:C2H2-type 6, 850118731$zinc finger region:C2H2-type 7, 850118734$zinc finger region:C2H2-type 8, 850118737$zinc finger region:C2H2-type 9]
